# Abbott Laboratories (ABT) — Q1-2017 Earnings Results

**Report date:** 2017-04-19 (before market open)  
**Sector:** Health Care / Health Care Equipment  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/ABT/earnings/Q1-2017

## Post-Earnings Brief

### Headline

Abbott Labs Beats on EPS, Stock Up 0.37%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.48 | N/A | +11.63% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed confidence in the company's strategic direction. They noted strong performance in certain segments, indicating potential for future growth.

**Key quotes:**

> Management highlighted strong performance in key product areas.

> They emphasized ongoing investments in innovation.

> The team remains focused on long-term growth despite market challenges.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Abbott Labs reported a better-than-expected EPS, which contributed to a slight increase in stock price. The positive surprise in earnings reflects the company's strong performance in specific product lines. However, the lack of revenue data and guidance leaves some uncertainty about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/ABT/earnings/Q1-2017_